Alfred Sandrock - 22 Mar 2022 Form 4 Insider Report for Voyager Therapeutics, Inc. (VYGR)

Role: President and CEO, Director
Signature: /s/ Robert Hesslein, as Attorney-in-Fact for Alfred Sandrock
Issuer symbol: VYGR
Transactions as of: 22 Mar 2022
Net transactions value: $0
Form type: 4
Filing time: 23 Mar 2022, 18:35:17 UTC
Previous filing: 09 Feb 2022
Next filing: 22 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VYGR	Common Stock	Award	$0	+100,000		$0.000000	100,000	22 Mar 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VYGR	Stock Option (Right to Buy)	Award	$0	+940,600		$0.000000	940,600	22 Mar 2022	Common Stock	940,600	$8.55	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Consists of shares of common stock issuable under an aggregate of 100,000 restricted stock units ("RSUs") awarded to the Reporting Person pursuant to the Voyager Therapeutics, Inc. 2015 Stock Option and Incentive Plan (the "Plan"). Each RSU represents the right to receive one share of common stock upon vesting. The vesting commencement date of the RSU award is April 1, 2022. The RSU award vests over four years, with 1/4th of the shares of common stock underlying the RSU award vesting on the one-year anniversary of such vesting commencement date and an additional 1/4th of the shares of common stock underlying the RSU award vesting at the end of each successive one-year period thereafter, subject to the Reporting Person's continued service as an employee.
F2	This stock option was issued pursuant to the Plan. The vesting commencement date of the option is the grant date, March 22, 2022. The option vests over four years, with 1/4th of the shares of common stock underlying the option vesting upon the one-year anniversary of such vesting commencement date and an additional 1/48th of the shares of common stock underlying the option vesting at the end of each successive one-month period thereafter, subject to the Reporting Person's continued service as an employee.

Content

Consists of shares of common stock issuable under an aggregate of 100,000 restricted stock units ("RSUs") awarded to the Reporting Person pursuant to the Voyager Therapeutics, Inc. 2015 Stock Option and Incentive Plan (the "Plan"). Each RSU represents the right to receive one share of common stock upon vesting. The vesting commencement date of the RSU award is April 1, 2022. The RSU award vests over four years, with 1/4th of the shares of common stock underlying the RSU award vesting on the one-year anniversary of such vesting commencement date and an additional 1/4th of the shares of common stock underlying the RSU award vesting at the end of each successive one-year period thereafter, subject to the Reporting Person's continued service as an employee.

This stock option was issued pursuant to the Plan. The vesting commencement date of the option is the grant date, March 22, 2022. The option vests over four years, with 1/4th of the shares of common stock underlying the option vesting upon the one-year anniversary of such vesting commencement date and an additional 1/48th of the shares of common stock underlying the option vesting at the end of each successive one-month period thereafter, subject to the Reporting Person's continued service as an employee.